Invention Grant
- Patent Title: Tablets comprising GLP-1 agonist and enteric coating
-
Application No.: US15543620Application Date: 2016-01-28
-
Publication No.: US10265384B2Publication Date: 2019-04-23
- Inventor: Birgitte Nissen , Flemming S. Nielsen , Patrick W. Garibay
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Rosemarie R. Wilk-Orescan
- Priority: EP15153000 20150129; EP15162589 20150407; WOPCT/EP2015/057442 20150407; EP15188737 20151007
- International Application: PCT/EP2016/051795 WO 20160128
- International Announcement: WO2016/120378 WO 20160804
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K38/26 ; A61K9/50 ; A61K38/17 ; A61K9/00 ; A61K35/00
Abstract:
The present invention relates to solid pharmaceutical compositions for oral administration comprising a GLP-1 agonist, an absorption enhancer which is a salt of medium-chain fatty acid, and an enteric coating as well as uses thereof.
Public/Granted literature
- US20180000903A1 Tablets Comprising GLP-1 Agonist and Enteric Coating Public/Granted day:2018-01-04
Information query
